Print

With Peptor Ltd. Acquisition Complete, DeveloGen AG Gets $22.8 Million Round Three 
10/19/2005 5:11:23 PM

DeveloGen, a German biotech start-up focused on treatments for metabolic disease, has completed its acquisition of Israeli drug discovery company Peptor, and the merged company has raised EUR19 million ($22.8 million) in a still-open round.
//-->